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Background: Some Ficus species have been used in traditional African medicine in the treatment of diabetes. The
antidiabetic potential of certain species has been confirmed in vivo but the mechanism of activity remains uncertain.
The aim was to investigate the hypoglycaemic potential of ten Ficus species focussing on glucose uptake, insulin
secretion and the possible mechanism of hypoglycaemic activity.
Methods: The dried and ground leaves of ten Ficus species were extracted with acetone. The dried acetone extract
was reconstituted with DMSO to a concentration of 100 mg/ml which was then serially diluted and used to assay for
glucose uptake in muscle, fat and liver cells, and insulin secretion in pancreatic cells.
Results: Only the F. lutea extract was able to modulate glucose metabolism. In comparison to insulin in the primary
muscle cells, the glucose uptake ability of the extract was 33% as effective. In the hepatoma cell line, the extract was as
effective as metformin in decreasing extracellular glucose concentration by approximately 20%. In the pancreatic
insulin secretory assay, the extract was 4 times greater in its secretory activity than commercial glibenclamide. With
F. lutea extract significantly increasing glucose uptake in the primary muscle cells, primary fat cells, C2C12 muscle and
H-4-II-E liver cells, the extract may act by increasing the activity of cell surface glucose transporters. When the 3T3-L1
pre-adipocytes were compared to the primary muscle, primary fat and C2C12 cells, the differences in the former’s ability
to transport glucose into the cell may be due to the absence of the GLUT4 transporter, which on activation via the insulin
receptor decreases extracellular glucose concentrations. Because the pre-adipocytes failed to show any active increase in
glucose uptake, the present effect has to be linked to the absence of the GLUT4 transporter.
Conclusion: Only F. lutea possessed substantial in vitro activity related to glucose metabolism. Based on the effect
produced in the various cell types, F. lutea also appears to be a partial agonist/antagonist of the insulin cell membrane
receptor. While the clinical effectiveness of F. lutea is not known, this plant species does possess the ability to modify
glucose metabolism.
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In many developing countries, herbal medicines are of
vital importance in primary health care [1]. This is sup-
ported by literature in behavioural and pharmacological
sciences with animals and people using a number of dif-
ferent plants species for the control of disease symptoms* Correspondence: vinny.naidoo@up.ac.za
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unless otherwise stated.and related illnesses [2,3]. One such disorder is diabetes
mellitus (DM) which is a chronic disease characterised
by prolonged hyperglycaemia, especially post-prandial,
in association with the consumption of diets that pro-
mote obesity, due to abnormalities in plasma insulin
concentrations.
Under normal physiological conditions, insulin is se-
creted by the β-cells of the pancreatic Islets of Langerhans
in the presence of increased plasma glucose concentrations
in a highly controlled manner. This potent anabolic
hormone subsequently decreases the plasma glucosel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of hepatic glucose production, increased macromolecular
synthesis of glycogen and triglycerides, and stimulation of
peripheral (skeletal muscle and adipose tissue) glucose
uptake [4,5]. Therefore any defects in the action or produc-
tion of insulin will lead to physiological hyperglycaemia of
DM [5]. Over time, this prolonged chronic hyperglycaemia
could result in microvascular and macrovascular damage,
causing long term complications such as neuropathy, ne-
phropathy, retinopathy, cardiovascular disease and impaired
wound healing that significantly interferes with quality of
life and life expectancy [5].
While several types of DM can occur, type I and type
II predominate. In type I diabetes, or insulin dependent
DM, the body has little or no insulin secretory capacity
and depends on exogenous insulin to prevent metabolic
disorders and death. In type II diabetes, a non-insulin
dependent DM, the body retains some endogenous insu-
lin secretory capability; however, insulin levels are low
relative to blood glucose levels and/or there is a mea-
sure of insulin resistance. Type II diabetes is the most
prevalent form of the disease, accounting for 90-95% of
cases globally [6,7].
While conventional treatments such as sulfonylureas,
metformin and thiazolidinedones are effective, they have
several limitations, including adverse side effects, second-
ary failure or the inability to halt further loss of insulin
secretory capacity [8]. Newer and cheaper medications are
therefore needed. One solution is to use herbal remedies,
which appear to be widely used with relatively few docu-
mented side effects [9].
Several species of the genus Ficus (family Moraceae)
are used traditionally in the management of diabetes
[10,11]: Ficus benghalensis L. [12], Ficus carica L. [13], Ficus
racemosa L. [14], Ficus hispida L. [15], Ficus microcarpa
L.f. [16], Ficus religiosa L. [17], Ficus thonningii Blume
[18], Ficus glumosa Del. [19], Ficus arnottiana Miq. [20],
Ficus glomerata Roxb. [21], F. sycomorus L. [22] and
F. deltoidea Jack [23]. Despite their widespread use,
the activity and possible mechanism of activity of Ficus
species is yet to be determined. The aim of this study was
therefore to investigate the mechanisms of the antidiabetic
activity, if any, of ten selected Ficus species.
Methods
Reagents and chemicals
Roswell Park Memorial Institute Medium 1640 (RPMI 1640),
foetal calf serum (FCS)/ foetal bovine serum (FBS), bovine
calf serum (BCS), glutamine, trypsin-EDTA, phosphate
buffered saline (PBS), sodium pyruvate, Hanks balanced
salt solution (HBSS), glucose oxidase kit (GAGO 20),
bovine serum albumin (BSA), Minimum Essential Medium
(MEM), Dulbecco’s MEM (DMEM), 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT), 2-[4-(2-hydroxyethyl)piperazin-1-yl]-ethanesulfonic acid (HEPES),
collagenase (type 11), penicillin/streptomycin, gliben-
clamide and D-glucose were purchased from Sigma
(South Africa). Gentamicin (Virbac), insulin (Sanofi Aventis),
Trypan blue (Fluka), doxorubicin (Pfizer) and Insulin
(Rat) ELISA kit (DRG Instruments GmbH, Germany
Frauenbergst). Sodium hydrogen carbonate (NaHCO3),
potassium chloride (KCl), sodium hydrogen phosphate
(NaH2PO4), calcium chloride (CaCl2), magnesium sulphate
(MgSO4), sodium chloride (NaCl), magnesium chloride
(MgCl2) potassium hydrogen phosphate (KH2PO4), di-
methyl sulphoxide (DMSO), acetone, methanol, hydrogen
chloride (HCl), sulphuric acid (H2SO4) and Whatman No.
1 filter paper were purchased from Merck (South Africa).
The absorbance measurements were read using a microti-
tre plate reader (VERSAmax, Molecular Devices, Labotec).
Cell lines and primary cell cultures
C2C12 mouse muscle myoblast (CRL-1772), 3T3-L1 mouse
pre-adipocytes fibroblast (CL-173), H411E rat hepatoma
(CRL-1548), and RIN-m5F rat insulinoma (CRL-11065)
were purchased from American Type Culture Collection
(ATCC) (Manassas, VA). The primary abdominal muscle
and epididymal fat pad were collected opportunistically
post-mortem from other animal studies, approved by
the Animal Use and Care Committee (AUCC) of the
University of Pretoria.
Plant material
The leaves of the ten Ficus species were collected at
the Manie van der Schijff Botanical Garden (University
of Pretoria), South Africa in February 2009. The names
of the plant species are Ficus capreifolia Delile, Ficus
cordata Thunb., Ficus craterostoma Warb. ex Mildbr.
& Burret, Ficus glumosa Delile, Ficus lutea Vahl, Ficus
natalensis Hochst., Ficus polita Vahl, Ficus religiosa
L., Ficus sycomorus L., and Ficus thonningii Blume. Voucher
specimens are placed in the HGWJ Schweickerdt Herbarium
of the same institution (for voucher numbers see Olaokun
et al. [24]). Leaf material was dried at room temperature,
milled to a fine powder (Macsalab mill, Eriez® Bramley) and
stored at room temperature in the dark until extracted [25].
Powdered material (2 g) was extracted with acetone (20 ml,
Merck technical grade) using a platform shaker (Labotec) at
room temperature for 30 min [26]. Extracts were centrifuged
at 500 × g for 5 min (Hettich centrifuge) filtered three times
(Whatman No. 1 filter paper), prior to drying at room
temperature under a stream of cold air. Crude extracts were
dissolved in DMSO (100%) to produce stock solutions of
100 mg/ml prior to some of the assays.
Isolation of compounds
Dried extract (74 g) re-dissolved in 50% acetone in
water, was successively and exhaustively partitioned
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dichloromethane, ethyl acetate and n-butanol (in order of
increasing polarity) [27]. With the F. lutea activity related
to glucose utilisation residing in the ethyl acetate fraction,
12 g ethyl acetate fraction was subjected to silica gel col-
umn chromatography eluting with increasing polarity of
n-hexane (n-hex), ethyl acetate (EtOAc) and methanol
(MeOH) mixtures to afford 115 fractions of 500 mL each.
Fractions 46–52 eluted with n-hex: EtOAc (70:30) were
also subjected to similar silica gel column chromatography
as fractions 10–30 followed by preparative TLC to afford a
compound of about 21 mg.
General experimental procedures
Column chromatography was performed on MN silica
gel 60 (0.063-0.2 mm/70–230) mesh. Pre-coated plates
of TLC silica gel 60 F254 (Merck, Germany) were used
for monitoring fractions and spots were detected with
UV light (254 and 365 nm) and then sprayed with 3%
H2SO4 followed by heating to 110°C. The structures of
compounds were elucidated using 1H and 13C nuclear
magnetic resonance (NMR) with spectra recorded
using a Bruker spectrometer at 500 MHz and Variant
spectrometer at 400 MHz. Chemical shifts (δ) were
quoted in parts per million (ppm) from internal stand-
ard tetramethylsilane (TMS).
Glucose uptake in established cell lines
Complete growth medium
Frozen vials of cells were revived according to ATCC
guidelines. The C2C12 myocytes were maintained in
DMEM culture medium supplemented with 10% foetal
bovine serum (FBS) and 4 mM glutamine. The 3T3-L1
pre-adipocytes were maintained in DMEM culture
medium supplemented with 10% bovine calf serum
(BCS) and 4 mM glutamine. The H-4-11-E hepatoma
cells were maintained in MEM culture medium supple-
mented with 10% FBS and 2 mM glutamine, while the
RIN-m5F insulinoma cells were maintained in RPMI-
1640 with 2 mM glutamine supplemented with 10%
FBS, 10 mM HEPES and 1 mM sodium pyruvate.
Glucose uptake was determined by the methods of
[28,29]. The C2C12 myocytes (25 000 cells/ml in DMEM
supplemented with 10% FBS), the 3T3-L1 pre-adipocytes
(30 000 cells/ml in DMEM supplemented with 10% BCS)
and the H-4-11-E hepatoma cells (30 000 cells/ml in MEM
supplemented with 10% FBS) seeded (200 μl) into wells of
96-well microtitre plates. After incubation at 37°C in a 5%
CO2 incubator for 4 days (C2C12 and 3T3-L1) and 2 days
(H-4-11-E), the medium in each of the wells was removed
and replaced with 100 μl of DMEM supplemented with
0.25% BSA containing plant extracts at concentrations of
15, 31, 63, 125, 250 and 500 μg/ml. The cells were subse-
quently incubated at 37°C in a 5% CO2 incubator for 1 h(C2C12), 1½ h (3T3-L1) and 3 h (H-4-11-E) with the vari-
ous treatments. Insulin (0.1 - 100 μM) served as the posi-
tive control for the C2C12 and 3T3-L1 cells and was
incubated for 1 h and 1½ h respectively while metformin
and insulin prepared in growth medium (0.1 - 100 μM)
were the positive controls for H-4-11-E cells. Cells treated
with metformin were incubated for 24 h. The solvent
control was 0.5% DMSO. Glucose concentration in the
medium was determined by the glucose oxidase method
(Sigma GAGO 20 test kit) according to instructions. All
experiments were carried out in triplicate and repeated
on three separate occasions (n = 9). When a plant ex-
tract tended to enhance glucose uptake, the effect was
re-tested in the presence of insulin at 1 μM and 10 μM.
Glucose uptake in primary cell cultures
Rat abdominal skeletal muscle
Rat abdominal muscle tissue was prepared using the
modified method of Gray and Flatt [30], from 8 week
old male Sprague–Dawley rats (n = 12) (170 – 250 g)
from the University of Pretoria Biomedical Research
Centre. Excised abdominal muscle was washed twice in
10 ml PBS, sectioned into 10-20 g pieces and transferred
into 20 ml Krebs-Ringer bicarbonate–bovine serum al-
bumin (KRB-BSA) pH 7.0 (consisting of 118 mM NaCl,
25 mM NaHCO3, 1.18 mM MgSO4, 1.25 mM CaCl2,
5 mM KCl, 1.17 mM KH2PO4 and 0.2% BSA) before
final gentle agitation at 37°C for 20 min in carbogen.
Each muscle square was then transferred into micro-titre
wells containing 450 μl KRB-BSA supplemented with
2 mM sodium pyruvate, 1 mM glucose and 50 μl of test
substance (n = 9) prior to incubation at 30°C for 45 min.
Final concentrations were plant extracts (12.5 – 200 μg/ml),
insulin (0.1 - 100 μM) and DMSO (1%). Glucose was quan-
tified as above and change in glucose concentration was
calculated using the following formula:
% glucose uptake
¼ 100 Absorbance control untreated cellsð Þ‐Absorbance sample treated cellsð Þ
Absorbance control untreated cellsð Þ
Rat epididymal adipose cells
Isolated adipocytes were obtained using the method of
Rodbell [31] as modified by Martz et al. [32]. The epididy-
mal fat pads (same rats as above) were rinsed in PBS and
finely minced and agitated at 37°C for 1 h in DMEM con-
taining 25 mM HEPES, collagenase type 11 (1 mg/ml), and
BSA (40 mg/ml). Cells were isolated by first filtration
(1000 μm nylon mesh) and subsequent centrifugation at
400 × g for 1 min. The bottom layer was finally aspirated
to obtain a cell layer. Isolated cells were washed three
times in HEPES buffered Krebs-Ringer solution, pH 7.0,
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MgSO4, 2.0 mM CaCl2, 2.5 mM KCl, 1 mM NaH2PO4,
1 mM sodium pyruvate and 1% BSA, penicillin (20 units/ml)
and streptomycin (20 mg/ml)) prior to final suspension
in the same buffer. Adipocyte number and viability were
determined by trypan blue exclusion. For assays, primary
adipocytes were suspended in medium supplemented
with 1 mM D-glucose, in a shaking water bath at 37°C
for 20 min. Cell suspension (200 μl) was plated at a
density of 1.0 × 103 cells/well in a 96-well microtitre
plate with 50 μl of plant extracts (n = 9), to yield final
concentrations of plant extract (12.5 – 200 μg/ml), in-
sulin (0.1, 1, 10, 100 μM) and DMSO (1%). Plates were
incubated at 37°C in a 5% CO2 incubator for 1 h, prior
to glucose quantification as above.
Insulin secretion assay
Insulin secretion by RIN-m5F cells was determined
by the method of Persaud et al. [33]. The RIN-m5F
insulinoma cells (100 000 cells/ml) were suspended in
RPMI-1640 supplemented with 10% FBS, 10 mM
HEPES and 1 mM sodium pyruvate (200 μl) into 96-
well plates. Cells were incubated at 37°C in a 5% CO2
incubator for 48 h, after which the medium was exchanged
for a glucose–free Krebs-Ringer bicarbonate (KRB) buffer
(135 mM NaCl, 3.6 mM KCl, 5 mM NaHCO3, 0.5 mM
NaH2PO4, 0.5 mM MgCl2 and 1.5 mM CaCl2) pH 7.4 sup-
plemented with 1 mg/ml BSA and 10 mM HEPES for a
further 2 h of incubation. The medium was subsequently
replaced with 100 μl of glucose–free KRB containing plant
extract (62.5 - 500 μg/ml), glibenclamide (0.1 - 10 μM) or
plain medium, and incubated at 37°C in a 5% CO2 for 1 h.
The insulin content of supernatants (n = 9) were deter-
mined using DRG diagnostic Insulin (Rat) ELISA kit, and
the following formula:
% Insulin secreted
¼ Absorbance sample treated cellsð Þ





To determine toxicity, cells were exposed to the ex-
tract or pure compound for 48 h of exposure prior to
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay [34]. In short, once confluent
the wells were rinsed with PBS (200 μl) and fresh medium
(200 μl) containing 30 μl of MTT (5 mg/ml in PBS) was
added to each well and further incubated for 4 h. Subse-
quently, the medium was aspirated without disturbing
the formazan crystals and replaced with 50 μl of DMSO.
The absorbance of the coloured formazan was measured
at 570 nm after gentle shaking using a microplate reader
(VERSAmax). The percentage cell viability was calcu-
lated as the absorbance of the treated well divided bythe absorbance of the solvent control well. The correlation
between percentage cell viability and percentage insulin
secretion was carried out.
Statistical analyses
All experiments were performed in triplicate and repeated
on three different occasions to yield nine dose–response
curves. Statistical analyses of glucose uptake assays and in-
sulin secretion were done by one-way analysis of variance
(ANOVA) and considered to be significantly different
at p <0.05. When significance was found, location of
significance was determined by Bonferroni and Tukey
HSD multiple comparison post hoc tests. The correlation
coefficients (R2) between viability of RIN-m5F pancreatic
β-cells and insulin secretion were also calculated. All
analyses were undertaken in SPSS 20 (IBM). Data are pre-
sented as the mean ± standard error of mean (S.E.M.).
Results
Glucose uptake activity in C2C12 muscle cells
The effect of the acetone leaf extracts of the ten Ficus
species on glucose uptake in C2C12 muscle cells is
presented in Figure 1A. Only F. lutea extract signifi-
cantly (p<0.001) enhanced glucose uptake in C2C12
muscle cells of 9.9 ± 2.7 μg/ml (14.9 ± 2.3%) at 500 μg/ml,
with no activity at concentrations below 63 μg/ml. DMSO
(solvent control) had a weak activity of 1.2 ± 0.2 μg/ml
(1.8 ± 0.3%), but insulin significantly (p<0.001) enhanced
glucose uptake of 12.7 ± 3.7 μg/ml (19.1 ± 3.7%) at a
10 μM. With F. lutea extract being partially effective on
C2C12 cell glucose uptake, the effect of the F. lutea in
the presence of insulin (1 μM and 10 μM) was evaluated
(Figure 1B). Insulin at the two concentrations, significantly
(p<0.001) increased the glucose uptake in the C2C12
muscle cells. In the presence 1 μM and 10 μM insulin the
F. lutea extract significantly (p<0.05) increased the glu-
cose uptake in the C2C12 muscle cells [13.0 ± 0.6 μg/ml
(19.5 ± 0.7%) and 13.9 ± 1.4 μg/ml (20.8 ± 1.6%) respectively]
at the highest concentration of 500 μg/ml compared to the
F. lutea extract alone. A marginal increase was seen for the
lower doses of F. lutea with insulin present in compari-
son to its absence. Surprisingly, insulin at both the
tested concentrations did not have the maximum effect
of 9.12 ± 0.23 μg/ml (13.7 ± 0.36%) and 12.7 ± 3.1 μg/ml
(19.1 ± 3.7%), when combined with the lower concentra-
tions of the F. lutea extract.
Extracellular glucose concentration of H-4-11-E liver cells
The effect of the acetone extracts of the ten Ficus spe-
cies on extracellular glucose concentration of H-4-II-E
liver cells is presented in Figure 2A. Only F. lutea extract
significantly (p<001) decreased extracellular glucose con-
centration [12.9 ± 0.6 μg/ml (19.3 ± 0.6%)] at the highest
concentration (500 μg/ml) into H-4-II-E liver cells. The
Figure 1 Glucose uptake in C2C12 muscle cells (A) expressed as percentage of untreated control cells ± standard error of mean, n = 9
exposed to the acetone extracts of the ten Ficus species or insulin and (B) expressed as percentage of untreated control cells ± standard
error of mean, (n = 9) exposed to insulin at 1 or 10 μM, in combination with F. lutea at various concentrations.
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activity of 2.3 ± 1.2 μg/ml (3.4 ± 1.8%), while metformin
and insulin significantly (p<0.001) decreased extracel-
lular glucose concentrations with the greatest decrease
being 12.0 ± 0.4 μg/ml (18.1 ± 0.6%) and 11.5 ± 0.1 μg/ml
(17.3 ± 0.1%) respectively. With only the F. lutea extract
being effective, the activity of the F. lutea extract in the
presence of insulin was investigated (Figure 2B). Ficus lutea,
at the highest concentration (500 μg/ml) in the presence of
insulin (concentrations of 1 μM and 10 μM, decreased the
extracellular glucose concentrations of H-4-II-E liver cells
significantly (p<0.05) [14.5 ± 1.2 μg/ml (21.8 ± 1.6%)] and
(p<0.001) [16.4 ± 1.3 μg/ml (24.6 ± 1.7%)] at both insulin
concentrations compared to the extract and insulin alone.
A marginal decrease was seen for the lower doses of
F. lutea with insulin present in comparison to its absence.
As above, insulin at both the tested concentrations did not
have its maximum effect of 10.7 ± 0.3 μg/ml) 16.0 ± 0.5%Figure 2 Extracellular glucose concentration of H-4-11-E rat liver cells (A
error of mean, n = 9 exposed to the acetone extracts of the ten Fic
of untreated control cells ± standard error of mean, n = 9 exposed to
various concentrations.and 11.5 ± 0.1 μg/ml (17.3 ± 0.1%), respectively when com-
bined with the F. lutea extract.
Glucose uptake in 3T3-L1 pre-adipocytes
No extract of any of the Ficus species enhanced glucose
uptake in the 3T3-L1 pre-adipocytes even at the highest
concentration of 500 μg/ml. Insulin, the positive control,
significantly (p<0.001) enhanced glucose uptake in
3T3-L1 pre-adipocytes with the highest glucose uptake
of 15.8 ± 1.8 μg/ml (23.7 ± 2.1%) at the concentration
10 μM while the uptake in the DMSO treated cells was
4.3 ± 0.9 μg/ml (6.5 ± 1.1%) (Figure 3).
Glucose uptake activity in primary cell culture
The effect of the acetone extracts of the ten Ficus species
on glucose uptake in primary rat abdominal muscle cul-
tures at 1 mM glucose is presented in Figure 4. Ficus lutea
extract at the concentration of 200 μg/ml induced the) expressed as percentage of untreated control cells ± standard
us species, insulin or metformin and (B) expressed as percentage
insulin at 1 or 10 μM, in combination with F. lutea at
Figure 3 Glucose uptake in 3T3-L1 pre-adipocytes (expressed as percentage of untreated control cells ± standard error of mean, n = 9)
exposed to the acetone extracts of the ten Ficus species or insulin.
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into muscle cultures but was not significantly different
(p<0.05) from glucose uptake induced by the extracts of
F. thonningii [5.4 ± 0.4 μg/ml (8.1 ± 0.7%)], F. natalensis
[4.7 ± 6.5 μg/ml (7.0 ± 7.7%)] and F. glumosa [3.9 ± 2.4 μg/ml
(5.9 ± 2.7%)] at the same concentration and in comparison
to the DMSO solvent control [3.8 ± 0.9 μg/ml (5.7 ± 1.4%)].
This uptake was only 33% of that induced by insulin
[23.8 ± 1.1 μg/ml (35.7 ± 1.0%)] at 100 μM. The effect
of the acetone extracts of the ten Ficus species on glu-
cose uptake in rat epididymal fat cells at 1 mM glucose
is presented in Figure 5. Only the extracts of F. lutea
and F. glumosa significantly (p<0.001) induced glucose
uptake in the primary fat cell cultures of 21.3 ± 6.2 μg/ml
(32.0 ± 8.4%) and 21.0 ± 4.8 μg/ml (31.6 ± 5.7%) respectively
at 200 μg/ml. As was the case for the abdominal muscle,
the solvent control (DMSO) also had some activityFigure 4 Glucose uptake (μg/ml) of rat abdominal primary muscle cu
extracts of the ten Ficus species and insulin in the present of 1 mM g[13.7 ± 3.9 μg/ml (20.6 ± 4.2%)]. Insulin was most effective
with uptake of 54.8 ± 1.1 μg/ml (82.2 ± 2.0%) at 100 μM.
Insulin secretion in RIN-m5F pancreatic cells
With only F. lutea extract having a good activity in
the above assays, the acetone extract of F. lutea was
also evaluated for its insulin secretory activity in RIN-
m5F pancreatic β-cells (Figure 6A). A concentration
dependent increase in insulin secretion was present
for F. lutea, with significant (p<0.001) increase from
6.3 ± 0.2 μg/L to 11.1 ± 0.3 μg/L (26.4 ± 6.4% to 120.8 ±
13.7%) from concentrations of 62.5 μg/ml to 500 μg/ml.
Glibenclamide also significantly (p<0.001) increased
insulin secretion in a concentration dependent man-
ner. An inverse linear correlation was present between
cell viability and insulin release for the F. lutea extract
(Figure 6B).ltures (± standard error of mean, n = 9) exposed to the acetone
lucose.
Figure 5 Glucose uptake (μg/ml) of rat epididymal primary fat cell cultures (± standard error of mean, n = 9) exposed to the acetone
extracts of the ten Ficus species and insulin in the present of 1 mM glucose.
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The 13C NMR and DEPT (Distortionless Enhancement
by Polarisation Transfer) spectra exhibited signals at δ
78.7, 66.1 and 28.1 ppm corresponding to carbons C-2,
C-3 and C-4 characteristic for a flavan-3-ol skeleton.
This was confirmed by the presence of important
signals on its 1H NMR spectrum at δ 4.87 (brs, H-2),
4.15 (m, H-3), 2.80 (dd, 4.4, 16.8 Hz, H-4a) and 2.62
(dd, 3.4, 16.6 Hz, H-4b) due to protons at positions C-2,
C-3 and C-4, respectively. Two sets of aromatic protons
were observed on its 1H NMR spectrum: the first set ap-
peared as two doublets at δ 5.98 (d, 2.2 Hz, H-8) and 5.87
(d, 2.2 Hz, H-6) due to the ring-A while the second one
appeared as AA'BB' system at δ 7.28 (d, 8.4 Hz, H-2'/H-6')
and 6.76 (d, 8.4 Hz, H-3'/H-5') corresponding to B-ring.
Furthermore, the 1H NMR spectrum also displayed three
downfield broad signals between 9.5 and 8.9 ppm assign-
able to three hydroxyl groups at C-4', C-7 and C-5. The
broad singlet multiplicity of proton H-2 was indicative toFigure 6 Insulin secreted by RIN-m5F pancreatic cells (A) expressed a
n = 6 exposed to the acetone extract of F. lutea and glibenclamide (p
between percentage cell viability of RIN-m5F pancreatic β-cells and pthis proton to be in cis configuration with proton H-3.
Moreover, the 13C NMR spectrum exhibited signals at δ
156.9, 156.2, 130.4 and 99.0 ppm corresponding to car-
bons C-7/C-4', C-5/9, C-1' and C-10, respectively. All
these data were in agreement with those published for
epiafzelechin (Figure 7) [35]. This compound which was
previously reported from Ficus cordata [36] is isolated
here for the first time from this species.
Effect of epiafzelechin on glucose uptake in C2C12
muscle cells
The effect of epiafzelechin on glucose uptake by the muscle
cells, in the presence of insulin was subsequently evaluated.
The uptake of glucose by C2C12 cells treated with epiafz-
elechin at different concentrations (15 μg/ml – 250 μg/ml)
in medium containing two different concentrations
of insulin (1 μM and 10 μM) is presented in Figure 8.
The insulin-mediated glucose uptake of C2C12 exposed
to epiafzelechin at different insulin concentrations ofs percentage of untreated control cells ± standard error of mean,
ositive control) in glucose free medium and (B) the correlation
ercentage insulin secretion by the acetone extract of F. lutea.
Figure 7 13C-NMR (125 MHz, CDCI3) Spectrum (A) and the structure of epiafzelechin (B) isolated from the leaf acetone extract of F. lutea.
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and 23.0 ± 0.7 μg/ml (34.5 ± 1.1%) respectively compared
to epiafzelechin alone [22.2 ± 0.9 μg/ml (33.4 ± 1.8%)] at
the highest epiafzelechin concentration (250 μg/ml). As
seen with the acetone extract, epiafzelechin decreased the
effectivity of insulin at the lower concentrations.Effect of epiafzelechin on extracellular glucose
concentration of H-4-11-E liver cells
The effect of epiafzelechin on glucose uptake by the H-4-
II-E liver cells, in the presence of insulin was evaluated.
The uptake of glucose by C2C12 cells treated with epiafz-
elechin at different concentrations (15 μg/ml – 250 μg/ml)
in medium containing two different concentrations of
insulin (1 μM and 10 μM) is presented in Figure 9. The
insulin-mediated glucose uptake in H-4-II-E liver cells
exposed to epiafzelechin at different insulin concentrations
of 1 μM and 10 μM was 24.6 ± 1.1 μg/ml (36.9 ± 1.0%) and
25.3 ± 0.7 μg/ml (37.9 ± 0.9%) respectively when compared
to epiafzelechin alone [21.6 ± 1.0 μg/ml (32.4 ± 1.5%)] at the
highest concentration (250 μg/ml). As seen with the acet-
one extract, epiafzelechin decreased the effectivity of insulin
at the lower concentrations.Effect of epiafzelechin on insulin secretion in RIN-m5F
pancreatic β-cells
Epiafzelechin was evaluated at different concentrations
(62.5 μg/ml – 500 μg/ml) for its ability to stimulate insulin
secretion in RIN-m5F pancreatic β-cells and was compared
with the untreated control cells. The RIN-m5F pancreatic
cells exposed to the epiafzelechin resulted in a dose related
increase in insulin secretion (Figure 10A). The insulin se-
creted significantly (p<0.001) increased from 7.2 ± 0.21 μg/L(47.1 ± 10.2%) at the concentration of 62.5 μg/ml to
11.2 ± 0.61 μg/L (123.9 ± 19.2%) at the concentration of
500 μg/ml. The correlation coefficient between the viability
of RIN-m5F pancreatic β-cells and insulin secretion by
the ethyl acetate fraction of the extract of F. lutea R2
was 0.66 (Figure 10B).
Discussion
Of the ten Ficus spp. evaluated, only F. lutea appeared
to have the ability to modulate glucose metabolism.
When the glucose uptake ability of the plant extract was
compared to insulin in the primary muscle cells, the
extract was 33% as effective. In the hepatoma cell line,
the F. lutea plant extract was as effective as metformin
in decreasing extracellular glucose concentration, by ap-
proximately 20%. In the pancreatic secretory assay, the
F. lutea extract was 4 times greater in its secretory
activity than commercial glibenclamide. As a result it
would appear that only F. lutea has merit in the man-
agement of type II diabetes.
The other aim of this study was to ascertain the mechan-
ism by which any of the plants could decreases extracellular
glucose concentration. This was facilitated through the use
of cell types with different transporter expression criteria
for the glucose transport receptors (GLUT), insulin secre-
tion and/or gluconeogenesis. The 3T3-L1 pre-adipocytes
predominantly express the GLUT1 glucose transporter
over GLUT4 [37]; the differentiated C2C12 myocytes
and the primary cells the GLUT4 transporter and the
H-4-II-E hepatoma cells the GLUT2 glucose transporter
[38]. While the 3T3-L1 pre-adipocytes can be transformed
into adipocytes that express the higher quantities of
GLUT4 transporter (5 fold higher), this transformation
step was not attempted for this study as we were only
Figure 8 Glucose uptake in C2C12 muscle cells (expressed as percentage of untreated control cells ± standard error of mean, n = 9)
exposed to insulin at 1 or 10 μM, in combination with epiafzelechin.
Olaokun et al. BMC Complementary and Alternative Medicine 2014, 14:269 Page 9 of 12
http://www.biomedcentral.com/1472-6882/14/269interested in using the pre-adipocytes as the control in
comparison to the other GLUT4 expressing cell lines
[39-42]. The hepatoma cell line was also used to study
the influence of the extract on gluconeogenesis [43],
while the pancreatic cells were used to evaluated insu-
lin secretory activity.
Based upon the poor glucose uptake by the non-
differentiated 3T3-L1 pre-adipocytes and the significantly
increasing glucose uptake in the primary muscle cells,
primary fat cells, C2C12 muscle and H-4-II-E liver cells, we
suspect that the F. lutea extract had its effect by increasing
the activity of cell surface glucose transporters either
directly or indirectly. With the 3T3-L1 pre-adipocytes
being poor in their glucose transporting ability due
to low levels of expression of the GLUT4 receptor, this
transporter must be considered a possible target site
[44]. Furthermore the plant extract did not have the
ability to induce differentiation in the pre-adipocytes,
indicating the absence of glucocortisteroid capacity.
However, with the hepatoma cell lines also showing
a decrease in extracellular glucose concentration, de-
creased gluconeogenesis (with effects being similar toFigure 9 Extracellular glucose concentration of H-4-11-E liver cells (ex
of mean, n = 9) exposed to insulin at 1 or 10 μM, in combination witmetformin) and/or increased GLUT2 transporter activ-
ity are other potential mechanisms. While it is possible
that the F. lutea plant extract is effective at multiple
pathways (GLUT4, GLUT2 and gluconeogenesis), a more
plausible explanation is that the extract stimulates the insu-
lin receptor, which on activation would increase GLUT4/2
transporter activity and/or decrease hepatic gluconeogen-
esis depending on the cell type. However, for the mechan-
ism of action to be fully characterised, further studies are
required. One such method could involve evaluating the
effects of the F. lutea acetone extract on glucose concen-
trations and/or tyrosine kinase activities, in the presence
of an antagonist of the insulin receptor. In studies using
the S961 peptide, Sprague Dawley rats showed both a
hyperglycaemia and hyperinsulinaemia response when
treated with this peptide [45]. If the effect seen by F. lutea
acetone extract is indeed mediated via the insulin receptor,
one would expect a competitive reduction in the effect
achievable or further downstream effects with increasing
concentrations of the antagonist added.
To further evaluate whether the effect of the F. lutea
extract was being mediated via the insulin tyrosine kinasepressed as percentage of untreated control cells ± standard error
h epiafzelechin.
Figure 10 Insulin secreted by RIN-m5F pancreatic cells (A) expressed as percentage of untreated control cells ± standard error of
mean, n = 6 exposed to epiafzelechin in glucose free medium and (B) the correlation between percentage cell viability of RIN-m5F
pancreatic β-cells and percentage insulin secretion by epiafzelechin.
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was compared to that with concurrent F. lutea, or to
F. lutea alone. The extract of F. lutea failed to further
enhance the effect of insulin. For both tissue types an
odd profile was attained, as the lower dose of F. lutea
appeared to inhibit the response to insulin, while the
high dose appeared to be marginally superior to insulin
alone, in a manner we consider to be mixed agonistic/
antagonistic activity. The latter response could also explain
why the plant extract achieved only a third of the effect of
insulin in the primary muscle tissue as it is in essence a par-
tial agonist when acting alone. This result was also similar
to that observed with resveratrol, a wine polyphenol which,
when used in the absence of insulin, enhanced muscular
uptake of glucose, but when added simultaneously to insu-
lin led to a time dependent diminishing of glucose uptake
in C1C12 muscle cells [46].
In the final step in elucidating the mechanism of action
of F. lutea, the influence of the plant extract on insulin
secretion was investigated. While not a completely effective
means of treating diabetes, the enhanced release of insulin
early on in the disease pathogenesis has been known to
ameliorate hyperglycaemia. The extracts of F. lutea stimu-
lated insulin secretion (9 fold) in the RIN-m5F pancreatic
cells in comparison to glibenclamide (5 fold). While our
result thus suggests that the extract of F. lutea could possess
insulin secretagogue properties, correlation analysis shows
an inverse correlation between cell viability and insulin re-
lease. This may suggest that the insulin secretory effect seen
was an artefact, more likely as a result of the high concentra-
tions inducing cell lyses as opposed to a physiological effect.
One of the compounds we isolated from F. lutea
acetone extract was identified as epiafzelechin. As far
as it could be established, this is the first study to dem-
onstrate that epiafzelechin has hypoglycaemic activity,
as previously shown for other polyphenolic compoundsusing in vitro muscle and fat cultures [47]. In this study,
epiafzelechin enhanced insulin secretory activity of RIN-
m5F pancreatic β-cells, albeit with correlation with cell
toxicity. It also enhanced glucose uptake in C2C12 muscle
cells and decreased extracellular H-4-II-E liver cells glu-
cose concentration in excess of that of the crude extract,
most likely due to the same agonistic/antagonistic insulin-
mimetic mode of action. When insulin and epiafzelechin
were added simultaneously to the C2C12 muscle and
H-4-II-E liver cells, there was no significant (p<0.05)
change in activity to that in the absence of insulin at
the highest concentration. These results are similar to
those observed by Ueda et al. [48], where epigallocate-
chin gallate stimulated a dose dependent increase in
glucose uptake of L6 muscle cells with no synergism
being present with insulin.
Conclusion
This study investigated the potential antidiabetic activity
of ten Ficus species, focussing on glucose uptake in muscle,
fat and liver cells; insulin secretion and safety through cyto-
toxicity assay. From these traditionally used plant species,
only F. lutea possessed substantial in vitro activity related
to glucose metabolism. When glucose uptake is compared,
the plant species was only 33% as effective as insulin.
In comparison to metformin, the plant extract was as
effective in inhibiting gluconeogenesis. The plant also
appears to lack direct insulin secretory activity. Based
on the effect produced in the various cell types, F. lutea
also appears to be a partial agonist/antagonist of the
insulin cell membrane receptor. However, for the true
effect of F. lutea to be established, in vivo oral rodent
efficacy studies in a disease model will be required. The lat-
ter is required to determine the biophasic availability of the
extract and/or its active constituents and its relationship to
efficacy following oral administration. More importantly
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the diseased state will also require elucidation.
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